Skip to main content
. 2020 Aug 27;106(10):2624–2632. doi: 10.3324/haematol.2020.256313

Figure 3.

Figure 3.

CDK6 alters the composition of the hematopoietic stem and progenitor pool. Analysis was performed 3 weeks post final polyinosinic–polycytidylic acid (poly(I:C)) injection. (A) Gating and representative flow cytometry pseudocolour plots. Percentage of (B) Lin-Sca-1+c-Kit+ (LSK) and (C) hematopoietic stem cells (HSC) (CD150+CD48-CD135-CD34-LSK) per 2.5x106 bone marrow (BM) cells (Cdk4Δ/Δ; Cdk6Δ/Δ; Cdk4/6fl/fl, n≥5/genotype). (D) Representative gating of DAPI/Ki-67 cell cycle staining of CD150+CD48+LSK (Fraction B) cells (E) and quantification of % cells in G0 (DAPI-, Ki-67-), G1 (DAPI-, Ki-67+) or S/G2/M (DAPI+, Ki-67+) cell cycle phase per 2.5x106 BM cells (n=3 (Cdk4Δ/Δ); n=3 (Cdk6Δ/Δ); n=6 (Cdk4/6fl/fl)). All comparisons were done with one-way ANOVA followed by Bonferroni’s Multiple Comparison Test, *P≤0.05, **P≤0.01, ***P≤0.001.